Drugs / G1P[8] human rotavirus vaccine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00334607 | Jun 2006 → Feb 2007 | Rotavirus infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT00139347 | Dec 2003 → Mar 2007 | Rotavirus infection | GlaxoSmithKline | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G1P[8] human rotavirus vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00334607 ↗ |
| Modality | Vaccine | “an attenuated G1P[8] human rotavirus (HRV) vaccine” PMID 16394298 ↗ Jan 2006 |
| Route | Oral | “Two oral doses administered to healthy infants” NCT00139347 ↗ |